RAPID NUTRITION PLC: Delivers Latest Market Update with Focus on New Innovative Products and International Growth
NEW YORK CITY, NY / ACCESSWIRE / June 1, 2020 / With a focus on international growth by further enhancing its product portfolio through new acquisitions, licensing, joint venture arrangements for its expanding distribution pipeline, Rapid Nutrition recently released a market update for investors and shareholders. A natural healthcare company focused on sports nutrition, diet management and life sciences products with extensive worldwide distribution, Rapid Nutrition (SWX:RAP) and (OTCQB:RPNRF) continues to grow operations and channels across the globe.
"Our company is entering an exciting stage where our growth and value are converging to create significant reach and further potential," said Executive Director and CEO Simon St. Ledger. "As we explore and prepare to launch first-in-class products while enhancing the sales reach of our current products, we look forward to the opportunities that will position us further as a global leader."
The key pillars of the company's growth involve expansion into neighboring countries and new distribution channels - with management recently securing new distributions agreements in Switzerland, Italy, France, Jamaica and Brazil - as well as product innovation and extension to complement its current stable of flagship brands, including the company's recent herbal formula to help relieve the severity of symptoms of common colds and flu. Further, Rapid Nutrition will continue to explore selective product acquisitions that complement current operations.
Rapid Nutrition's award-winning nutraceutical brand SystemLS, which contain proven and effective dose to target the main issues relating to weight management, include:
"Our experienced and entrepreneurial management team continues to be an asset as we endeavor to attract more industry leaders and partners, allowing the group to continue to execute on its strategy to grow the business, leverage our assets and to develop opportunities." St. Ledger added. "We approach the second half of the year poised for development, growth and success. We look forward to updating our shareholders as these corporate events and activities progress."
The latest update and company presentation is available through Rapid Nutrition's Investor Relations site.
About Rapid Nutrition
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. For more information, please visit http://rnplc.com
Investor Relations Contact
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).
SOURCE: Rapid Nutrition PLC via EQS Newswire
06/01/2020 EQS Newswire / EQS Group AG